Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 15, 2024

Olanzapine Plus Triple Antiemetic Therapy for Preventing Carboplatin-Induced Nausea and Vomiting

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
J. Clin. Oncol 2024 Jun 04;[EPub Ahead of Print], N Inui, T Suzuki, K Tanaka, M Karayama, Y Inoue, K Mori, H Yasui, H Hozumi, Y Suzuki, K Furuhashi, T Fujisawa, S Matsuura, K Nishimoto, T Matsui, K Asada, D Hashimoto, M Fujii, M Niwa, M Uehara, H Matsuda, K Koda, M Ikeda, N Inami, Y Tamiya, M Kato, H Nakano, Y Mino, N Enomoto, T Suda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading